FDA Limits On Vasopressin Compounding Valid, Says Judge
A D.C. federal judge on Thursday chucked a challenge to the U.S. Food and Drug Administration's limits on drug compounding with the hormone vasopressin, rejecting assertions that the agency is improperly...To view the full article, register now.
Already a subscriber? Click here to view full article